(2) request a formulary exception with documentation showing Wegovy didn't work or you have contraindications
Main GLP1 and Related Brands Leading GLP-1 medications in 2025 include semaglutide (marketed as Ozempic for diabetes and Wegovy for weight loss), liraglutide (Victoza for diabetes, Saxenda for weight loss), tirzepatide (Mounjaro for diabetes, Zepbound for weight loss), dulaglutide (Trulicity for diabetes) and oral semaglutide (Rybelsus)
This makes them lightweight, but susceptible to damage
The targeted metabolic action of the Glenmark Glipiq Semaglutide molecule offers efficient clinical management across step-up indications
Divinski I, Mittelman L, Gozes I
Preserving lean muscle mass: muscle tissue burns more calories than fat, even at rest